ZYMEWORKS

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. The company is committed to developing best-in-class protein therapeutics for the treatment of cancer, autoimmune, and inflammatory diseases. Zymeworks' approach combines proprietary molecular modeling and simulation software with high-performance computing to create an environment for in silico experimentation and predictive protein optimization. Using this approach Zymeworks has developed multiple platform technologies to advance the field of biologics drug discovery and optimization. It was founded in 2004 and headquartered in Vancouver, British Columbia.

#SimilarOrganizations #People #Financial #Event #Website #More

ZYMEWORKS

Social Links:

Twitter

Industry:

Biotechnology Medical Therapeutics

Founded:

2004-04-01

Address:

Vancouver, British Columbia, Canada

Country:

Canada

Website Url:

http://www.zymeworks.com

Total Employee:

101+

Status:

Active

Contact:

(604)678-1388

Email Addresses:

[email protected]

Total Funding:

845.77 M USD

Technology used in webpage:

Font Awesome Domain Not Resolving Mobile Non Scaleable Content ReCAPTCHA BootstrapCDN JQuery CDN ReCAPTCHA V2 New Relic Apple Whitelist Amazon Oregon Region

Similar Organizations

1859-logo

1859

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

kymera-therapeutics-logo

Kymera Therapeutics

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

translate-bio-logo

Translate Bio

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.

tango-therapeutics-logo

Tango Therapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Current Advisors List

ali-tehrani_image

Ali Tehrani Member of the Board of Directors @ Zymeworks
Board_member

kenneth-galbraith_image

Kenneth Galbraith Board Member @ Zymeworks
Board_member

haig-farris_image

Haig Farris Board Member @ Zymeworks
Board_member

noel-hall_image

Noel Hall Board Member @ Zymeworks
Board_member

not_available_image

Ian Ihnatowycz Board Member @ Zymeworks
Board_member

don-drakeman_image

Don Drakeman Board Member @ Zymeworks
Board_member

not_available_image

Nick Bedford Chairman @ Zymeworks
Board_member

shermaine-tilley_image

Shermaine Tilley Board Member @ Zymeworks
Board_member

Current Employees Featured

ali-tehrani_image

Ali Tehrani
Ali Tehrani President & CEO @ Zymeworks
President & CEO
2004-01-01

surjit-dixit_image

Surjit Dixit
Surjit Dixit Vice President Technology @ Zymeworks
Vice President Technology
2017-01-01

neil-klompas_image

Neil Klompas
Neil Klompas Chief Financial Officer & EVP Business Operations @ Zymeworks
Chief Financial Officer & EVP Business Operations
2007-01-01

john-babcook_image

John Babcook
John Babcook Distinguished Fellow @ Zymeworks
Distinguished Fellow
2021-03-01

tony-polverino_image

Tony Polverino
Tony Polverino EVP Early Development & CSO @ Zymeworks
EVP Early Development & CSO
2018-09-01

rhonda-wideman_image

Rhonda Wideman
Rhonda Wideman Senior Director, Business Development & Alliance Management @ Zymeworks
Senior Director, Business Development & Alliance Management
2021-01-01

kenneth-galbraith_image

Kenneth Galbraith
Kenneth Galbraith Chair & Chief Executive Officer @ Zymeworks
Chair & Chief Executive Officer
2022-01-01

jennifer-kaufman-shaw_image

Jennifer Kaufman-Shaw
Jennifer Kaufman-Shaw VP Intellectual Property and Legal Affairs @ Zymeworks
VP Intellectual Property and Legal Affairs
2014-08-01

paul-moore_image

Paul Moore
Paul Moore Chief Scientific Officer @ Zymeworks
Chief Scientific Officer
2022-07-01

kathy-odriscoll_image

Kathy O&s;Driscoll
Kathy O'Driscoll Chief People Officer @ Zymeworks
Chief People Officer
2019-10-01

Founder

ali-tehrani_image

Ali Tehrani

anthony-fejes_image

Anthony Fejes

Stock Details

Company's stock symbol is NYSE:ZYME

Acquisitions List

Date	Company	Article	Price
2016-03-22	Kairos Therapeutics	Kairos Therapeutics acquired by Zymeworks	N/A

Investors List

business-development-bank-of-canada_image

Key Employee Changes

Date	New article
2022-07-22	Zymeworks Reports Inducement Grant to New Chief Scientific Officer
2022-06-27	Zymeworks Appoints Dr. Paul Moore as Chief Scientific Officer
2022-01-20	Zymeworks replaces half its C-suite, aims to lay off 25% of total workforce as new CEO takes over
2022-01-05	Zymeworks Names Biotechnology Industry Leader Kenneth Galbraith as Chair and CEO to Succeed Dr. Ali Tehrani

Official Site Inspections

http://www.zymeworks.com Semrush global rank: 3.74 M Semrush visits lastest month: 3.62 K

Host Informations
Whois Informations

Loading ...